(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 5. Microinjection of Xfoxi1a mRNA induces epidermal differentiation
and suppresses neural induction in both in vivo and in vitro. Xfoxi1a
mRNA (25 pg/cell) was injected into two unilateral blastomeres of eight-cell
embryos. Embryos were fixed at stage 14-15 and then whole-mount in situ
hybridization was performed with the following probes. (A) Sox2, (B)
XK81, (C) Dlx3, (D) FoxD3 and (E) Six1.
(A-D) Dorsal view (anterior towards top); (E) anterior view (dorsal towards
the top). Dashes indicate the midline. White arrows indicate the injected
side. The activity of Xfoxi1a (12.5 pg/cell) was assessed by RT-PCRs
in Chd (50 pg/cell)-injected animal caps (F) or dominant-negative Bmp
receptor (dnBMPR) (100 pg/cell)-injected animal cap (G). RNAs were
injected into all the animal blastomeres of eight-cell embryos. The animal
caps were excised at stage 9 and cultured until sibling embryos reached stage
15. The expression patterns of the neural marker Sox2, the non-neural
ectodermal markers (XK81, Dlx3, Msx1, Xfoxi1a, Bmp4), the mesodermal
marker MyoD were analyzed. H4 was used as the loading control.